Copyright
©The Author(s) 2022.
World J Gastrointest Surg. Dec 27, 2022; 14(12): 1320-1328
Published online Dec 27, 2022. doi: 10.4240/wjgs.v14.i12.1320
Published online Dec 27, 2022. doi: 10.4240/wjgs.v14.i12.1320
Ref. | Drugs | Type of study | Number of patients | Observations | Conclusion |
Cohen et al[68], 2022 | TNFis | Prospective study | 947 | Postoperative infection rate | No correlation |
Uchino et al[69], 2022 | TNFis | Retrospective study | 305 | Surgical mortality | No correlation |
Abd El Aziz et al[70], 2022 | TNFis | Prospective study | 274 | Intra-abdominal septic complications | No correlation |
Azzam et al[71], 2022 | Azathioprine | Retrospective study | 105 | Endoscopic recurrence rate | Negative correlation |
Cosnes et al[72], 2005 | Azathioprine | Retrospective study | 2573 | Intestinal complications | No correlation |
Nguyen et al[73], 2014 | Steroids | Retrospective study | 15495 | Postoperative sepsis and VTE | Positive correlation |
- Citation: Xia K, Gao RY, Wu XC, Yin L, Chen CQ. Timing of individualized surgical intervention in Crohn’s disease . World J Gastrointest Surg 2022; 14(12): 1320-1328
- URL: https://www.wjgnet.com/1948-9366/full/v14/i12/1320.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v14.i12.1320